Aratana to Present at Bank of America Merrill Lynch Animal Health Summit

KANSAS CITY, Kan., Dec. 7, 2012 /PRNewswire/ -- Aratana Therapeutics, a biopharmaceutical company developing innovative medicines for cats and dogs (companion animals), today announced that it will participate in Bank of America Merrill Lynch's Animal Health Summit, taking place December 11, 2012, at the Bank of America Conference Center in Boston, MA.

Steven St. Peter , M.D., President and Chief Executive Officer of Aratana, will present a company overview at 2pm ET, and will also host one-on-one and small group meetings with investors.  Dr. St. Peter will be joined by Louise Mawhinney , CPA, Chief Financial Officer, and Linda Rhodes , V.M.D., Ph.D., Chief Scientific Officer of Aratana Therapeutics. 

About Aratana Therapeutics
Aratana Therapeutics is a biopharmaceutical company positioned to deliver high quality new medicines that address significant therapeutic needs for cats and dogs (companion animals).  Aratana licenses and develops proprietary, patent-protected compounds acquired from human pharmaceutical and biotechnology companies and then develops strategies to maximize the value of the programs for the animal health market.  For more information, please visit www.aratanatherapeutics.com.

For Investors & Media:
Joshua Drumm , Ph.D. / Andrew Mielach
Tiberend Strategic Advisors, Inc.
(212) 827-0020
jdrumm@tiberend.com  
amielach@tiberend.com 

SOURCE Aratana Therapeutics

RELATED LINKS
http://www.aratanatherapeutics.com